01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
Earlier this month, New York State passed a new law prohibiting discrimination against employees bas...
Read More >
Criminal investigations will target businesses profiting from the importation into the United States...
Read More >
On September 28, 2020 Governor Gavin Newsom signed into law Assembly Bill (“AB”) 1561, which exten...
Read More >
In the October 2019 Visa Bulletin issued by the US Department of State, EB-2 and EB-3 worldwide empl...
Read More >
New York will see a slew of new labor laws in 2020 which may have a substantial impact on employers ...
Read More >
We have created a chart on current investment preferences in Kazakhstan, which includes territory, e...
Read More >